Loading...

PROCEPT BioRobotics Corporation

PRCTNASDAQ
Healthcare
Medical - Devices
$55.72
$-2.92(-4.98%)

PROCEPT BioRobotics Corporation (PRCT) Company Profile & Overview

Explore PROCEPT BioRobotics Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

PROCEPT BioRobotics Corporation (PRCT) Company Profile & Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

SectorHealthcare
IndustryMedical - Devices
CEOReza Zadno

Contact Information

650 232 7200
900 Island Drive, San Jose, CA, 94065

Company Facts

756 Employees
IPO DateSep 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;